Minjong Lee Associate Professor
College of Medicine
- Esther Building #1030
Research Record
- Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinoma International journal of surgery (London, England), 2024, v.110 no.2, 1008-1018
- Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2024, v.84 no.5, 206-214
- PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B Journal of Hepatology, 2024, v.80 no.1, 20-30
- 만성 B형간염에서 혈청표지자와 간섬유화 스캔을 이용한 간섬유화 평가 대한소화기학회지, 2024, v.84 no.5, 206-214
- Association of Physical Activity With Risk of Liver Fibrosis , Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, v.21 no.2, 358-
- Bioreducible exosomes encapsulating glycolysis inhibitors potentiate mitochondria-targeted sonodynamic cancer therapy via cancer-targeted drug release and cellular energy depletion Biomaterials, 2023, v.301, 122242
- COVID-19 감염 후 발생한 비전형적 형태의 간농양 대한소화기학회지, 2023, v.82 no.2, 102-104
- Exosome membrane-sheathed and multi-stimuli-responsive MnO2 nanoparticles with self-oxygenation and energy depletion abilities potentiate the sonodynamic therapy of hypoxic tumors Chemical Engineering Journal, 2023, v.472, 144871
- Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes Gut and liver, 2023, v.17 no.4, 610-619
- Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease LIVER INTERNATIONAL, 2023, v.43 no.3, 608-625
- Piezocatalytic 2D WS2 Nanosheets for Ultrasound-Triggered and Mitochondria-Targeted Piezodynamic Cancer Therapy Synergized with Energy Metabolism-Targeted Chemotherapy Advanced Materials, 2023, v.35 no.18, 2300437
- Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease Clinical Gastroenterology and Hepatology, 2023, v.21 no.9, 2298-2.31E21
- 면역관용기에서 면역활동기로 접어드는 HBeAg 양성인 만성 B형간염 환자에서 간세포암종의 발생에 대한 예측모델 개발 대한소화기학회지, 2023, v.82 no.6, 313-314
- Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study Clinical and Molecular Hepatology, 2022, v.28 no.3, 540-552
- 항바이러스제 치료 중인, 간경변증이 없는 e항원 양성인 만성 B형간염 환자에서 치료 전 바이러스 수치와 간세포암종 발생의 연관성 대한소화기학회지, 2022, v.80 no.3, 161-162
- [학술지논문] Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinoma INTERNATIONAL JOURNAL OF SURGERY, 2024, v.110 no.2 , 1008-1018
- [학술지논문] PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B JOURNAL OF HEPATOLOGY, 2024, v.80 no.1 , 20-30
- [학술지논문] Association of Physical Activity With Risk of Liver Fibrosis , Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, v.21 no.2 , 358-+
- [학술지논문] Bioreducible exosomes encapsulating glycolysis inhibitors potentiate mitochondria-targeted sonodynamic cancer therapy via cancer-targeted drug release and cellular energy depletion BIOMATERIALS, 2023, v.301 no.- , 122242-122242
- [학술지논문] Exosome membrane-sheathed and multi-stimuli-responsive MnO2 nanoparticles with self-oxygenation and energy depletion abilities potentiate the sonodynamic therapy of hypoxic tumors CHEMICAL ENGINEERING JOURNAL, 2023, v.472 no.- , 144871-144871
- [학술지논문] Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease LIVER INTERNATIONAL, 2023, v.43 no.3 , 608-625
- [학술지논문] Piezocatalytic 2D WS2 Nanosheets for Ultrasound-Triggered and Mitochondria-Targeted Piezodynamic Cancer Therapy Synergized with Energy Metabolism-Targeted Chemotherapy ADVANCED MATERIALS, 2023, v.35 no.18 , 2300437-2300437
- [학술지논문] Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, v.21 no.9 , 2298-+
- [학술지논문] Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study DIABETES & METABOLISM, 2022, v.48 no.5 , 101362-101362
- [학술지논문] Outcome of Intermittent Thoracentesis versus Pigtail Catheter Drainage for Hepatic Hydrothorax JOURNAL OF CLINICAL MEDICINE, 2022, v.11 no.23 , 7221-7221
- [학술지논문] Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department A multicenter study CLINICAL AND MOLECULAR HEPATOLOGY, 2022, v.28 no.3 , 540-552
Courses
-
2025-1st
-
Digestive system
- Subject No 37615Class No 01
- 2Year ( 3Credit , 69Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2024-1st
-
Digestive system
- Subject No 37615Class No 01
- 2Year ( 3Credit , 69Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2023-2nd
-
Sympathetic Communication 강의 계획서 상세보기
- Subject No 37498Class No 01
- 2Year ( 3Credit , 3Hour) Thu 5~6 (D)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2023-1st
-
Digestive system
- Subject No 37615Class No 01
- 2Year ( 3Credit , 69Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-